annual report 2016 · joanne smith donna m. stearns elizabeth straus arlene taub karen taub jamie...

Annual Report 2016 | 1

A N N UA L R E P O RT 2 0 1 6

2 | Breast Cancer Research Foundation

Our LeadersOur Approach Our GrowthScientific LeadershipAreas of Focus Tumor Biology Heredity & Ethnicity Lifestyle & Prevention Treatment Metastasis SurvivorshipSupport from Coast to Coast Events & Community Corporate Partnerships The Power of PhilanthropyGranteesFinancials

34567–12

13–19

20–2223

MISSIONThe Breast Cancer Research Foundation (BCRF) is committed to being the end of breast cancer by advancing the world’s most promising research. Founded by Evelyn H. Lauder in 1993, BCRF-funded investigators have been deeply involved in every major breakthrough in breast cancer research. By committing 91 cents of every dollar directly to its mission, BCRF remains one of the nation’s most fiscally responsible nonprofits. BCRF is the only breast cancer organization in the US with an “A+” from CharityWatch and has been awarded Charity Navigator’s highest rating of four stars 14 times since 2002.

Visit www.bcrfcure.org to learn more.

Arlene AdlerRoberta M. AmonMelinda BlinkenLouise L. BraverAndrea BrooksSusan Payson BurkeElisha DanielsIris DanknerSuzanne ElsonAnne Eisenhower FlöttlStephanie GinsbergRoslyn GoldsteinMarjorie Reed GordonLorna Hyde Graev

Betsy S. GreenBette-Ann GwathmeySusan HertogRonnie HeymanGail HilsonSusan B. HirschhornLinda HollidayJane Hertzmark HudisElizabeth HurleyAlice JacksonJayne JamisonNancy KelleherStacie KiratsousRochelle Kivell

Lisa KleinSandra KrakoffElyse LacherMaralyn LakinLaura LassmanHeather LeedsNancy MahonMarisa Acocella Marchetto Mary Bryant McCourtKim MeyersDarcy Miller NussbaumEllen Odoner, Esq.Mary Alice Pappas

Winifred Gorlin PhillipsJane PontarelliPatricia Quick Lisa QuirozKatharine RaynerAndrea RedmondLynda ResnickWendi RosePatricia RosenwaldJudith P. SchlagerNicole SeagriffBari Seiden-YoungAnne SitrickJoanne Smith

Donna M. StearnsElizabeth StrausArlene TaubKaren TaubJamie TischKelley TuthillLinda WaintrupCathy WeinrothHarriet WeintraubCandace King WeirNina WexlerSimone WinstonSara Wolfensohn

Leonard A. Lauder, Honorary Chairman Kinga Lampert, Co-Chairman William P. Lauder, Co-Chairman

Myra J. Biblowit, President & CEO Deborah Krulewitch, SecretaryRobert J. Bigler, Treasurer

Larry Norton, MD, Scientific DirectorBetsy L. BattleMaria BaumClarissa Alcock BronfmanTory Burch

Cindy Citrone Kay KrillLaura LangCarolee Lee Blythe MastersCarlyn McCaffrey, Esq.Abbe Raven

Teruca RullánEvelyn H. Lauder, Founder, in memoriamCynthia Lufkin, Vice Chair, in memoriam

ADVISORY BOARD (as of February 2017)

BOARD OF DIRECTORS


Evelyn H. Lauder established the Breast Cancer Research Foundation because she saw an urgent need for an organization exclusively dedicated to advancing research. Since then, BCRF’s global network of investigators has been deeply involved in every major breakthrough in breast cancer prevention, diagnosis, treatment, metastasis and survivorship. This year alone we have awarded $57 million in grants to more than 250 scientists and clinicians at leading medical and academic institutions across 14 countries, making BCRF the largest private funder of breast cancer research in the world. We are tackling breast cancer on all fronts by funding research across the entire spectrum of the disease, including:

• Uncovering the very roots of cancer by studying tumor biology • Understanding the role of genetic susceptibility• Reducing breast cancer risk through lifestyle and prevention strategies • Developing targeted treatments to outsmart cancer • Improving quality of life during and after treatment• Unravelling the mystery of metastasis

With the scientific freedom provided by BCRF funding, well over half a billion dollars has fueled innovations and novel approaches to discovery. Investing in research produces tangible results—there are 3.5 million breast cancer survivors in the country today. The number of deaths have dropped by 30 percent over the last 20 years. Progress is undeniable, but more needs to be done. With no known cure, more than 40,000 Americans will die this year from metastatic breast cancer. BCRF is confident that lifesaving discoveries lie in wait. Led by the vision of an esteemed board of directors comprised of trailblazers in business, media, and philanthropy, alongside a scientific advisory board with the best minds in science, we are closer than ever to fulfilling our mission: to be the end of breast cancer.

Sincerely,

A LETTER FROM BCRF LEADERSHIP

Myra J. BiblowitPresident and CEO

Kinga LampertCo-Chairman

William P. LauderCo-Chairman

O U R L EA D E R S

4 | www.bcrfcure.org

When BCRF was founded, a breast cancer diagnosis invoked fear and little hope. Scientific understanding of the nature of the disease and how it moved through the body was still nascent. Investigations on prevention strategies were new, screening methods were limited and treatment options were few.

The scientific community has discovered more about breast cancer, and all cancers, in the past two decades than it has in the last 100 years.

Since 1990, after remaining stagnant for more than 50 years, the rate of deaths due to breast cancer has declined by more than 30 percent; and five-year survival rates of breast cancer are better than 90 percent when detected and treated early. We are moving beyond a “one-size-fits-all” approach to treatment with the development of targeted, more effective therapies for patients. Advances in treatment and early detection are why there are more than 3.5 million women with a history of breast cancer alive in the U.S. today.

These milestones are the results of research. Research is revolutionizing our understanding of cancer. Research is leading us to the core of this insidious disease. Research is bringing an end to cancer as we know it. When Evelyn Lauder and Dr. Larry Norton, BCRF’s Scientific Director, created BCRF more than 20 years ago, they realized the irrefutable power of research. They saw its potential to unlock the complexities of cancer and change the lives of millions of women and men worldwide.

Mrs. Lauder and Dr. Norton grounded their vision in an innovative grant-making process that values freedom, creativity and collaboration just as much as rigor and accountability. Nearly 25 years later, BCRF is as committed as ever to not only helping the most brilliant minds in science and medicine pursue big-impact ideas, but also moving those ideas from the lab to the patient as quickly as possible.

O U R A P P ROAC H


1993 to 2016

When BCRF was formed there was little understanding of the nature of breast cancer and how it moved through the body. The support from BCRF’s dedicated community — our donors, partners, researchers and all those affected by the disease — has changed that.

This year BCRF is investing $57 million in research and supporting more than 250 investigators across 14 countries, making us the largest private funder of breast cancer research in the world. We must maintain the momentum of accelerating advances to improve the lives of those affected by this disease. The need is urgent; every moment spent in the lab is a moment closer to finding a cure.

1 140Corporate Partners

1 14Countries

8 250Researchers

in Grants

$160 THOUSAND

$57 MILLION

O U R G ROWT H

From the beginning, BCRF has sought the most brilliant researchers to unravel the complexities of cancer. We fund people – not projects – and it is because of them that BCRF is a longstanding leader in breast cancer research.

Our Scientific Advisory Board (SAB) directs BCRF’s research efforts by seeking out the promise and potential in individuals around the world who can bring us closer to the end of cancer. Each year, BCRF’s Scientific Advisors invite proposals from pioneering laboratory scientists and clinical investigators making headway in cancer research. After careful deliberation and an assessment of the most promising leads, the SAB awards grants once a year.

“It is clear that we have made significant progress toward eradicating breast cancer and while there is much more to be accomplished, the pace toward that goal is rapid and accelerating,” said Dr. Larry Norton, BCRF Scientific Director. “BCRF’s approach—attacking breast cancer from all angles and giving brilliant investigators freedom and collegial spirit to rise to their best work—has provided great impetus and offers tremendous hope.”

With each grant awarded, BCRF’s scientific leaders demonstrate trust in the distinguished investigators to collaborate, pursue creative ideas and explore promising breakthroughs. Our areas of focus span the spectrum of breast cancer research including tumor biology, heredity and ethnicity, lifestyle and prevention, treatments, survivorship, and metastasis—tackling breast cancer on all fronts.

“One of BCRF’s defining characteristics is its willingness to take risks by giving scientists the freedom to be innovative, daring and original,” said Dr. Judy Garber, Chairman of BCRF’s Scientific Advisory Board. “We don’t expect everything to work, but we do expect there to be real advances in science. Our reward is in lives saved.”


ACHIEVING OUR MISSION

BCRF SCIENTIFIC ADVISORY BOARD

Larry Norton, MD Scientific Director Memorial Sloan Kettering Cancer Center

Judy E. Garber, MD, MPH Chairman Dana-Farber Cancer Institute Harvard Medical School

Joan S. Brugge, PhD Harvard Medical School

Nancy E. Davidson, MD Fred Hutchinson Cancer Research Center, University of Washington

Susan M. Domchek, MD University of Pennsylvania

Patricia A. Ganz, MD University of California, Los Angeles

Peter Greenwald, MD, DrPH National Cancer Institute National Institutes of Health

Gabriel N. Hortobagyi, MD, FACP MD Anderson Cancer Center, University of Texas

Martine J. Piccart-Gebhart, MD, PhD Institut Jules Bordet

Lajos Pusztai, MD, DPhil Yale University School of Medicine

Vered Stearns, MD Johns Hopkins School of Medicine

S C I E N T I F I C L EA D E R S H I P


THE ROOTS OF CANCER: TUMOR BIOLOGYResearch on the biology of cancer starts with the simplest of questions: What is—and isn’t—a normal cell? How does a normal cell become cancerous? Why does it grow out of control to form a tumor and spread, a process known as metastasis, to other parts of the body?

Thanks to the groundbreaking work of Dr. Charles Perou and colleagues, we now know that breast cancer is, in fact,several diseases, each of which develops, progresses and responds to therapies differently.

Research Highlights Our investigators are exploring the unique characteristics of cancer cells, how and why they transform from normal to abnormal and what drives a tumor’s response to any particular treatment. Because of groundbreaking research, we are learning that breast cancers share commonalities with cancers arising in other organs.

Some BCRF investigators are looking within cells (at DNA, RNA, and proteins) to gain a deeper understanding of what makes a cancer cell. For example, Dr. Lewis Chodosh and others are working to identify specific genes and pathways by which breast cancer recurs to develop targeted therapies.

Investigators have also focused on interactions outside of the cell. In addition to pioneering the use of 3D culture models that replicate breast tumors, Dr. Mina Bissel and others are studying the interactions of the tumor cell and its surrounding environment to identify signals of metastasis and targets for therapy.

Simultaneously, several BCRF investigators have taken a step back to study the various cells that make up a tumor. Work by Drs. Kornelia Polyak, Charles Swanton and colleagues have shown that each breast tumor can contain several types of cancer cells. This might be why current therapies do not work for some patients and why novel approaches are being developed to deal with such complexity.

Understanding the basic biology of breast cancer is allowing us to get to the very core of the disease. Every aspect, from a cancer cell’s genes to the tumor’s environment, is under investigation. BCRF scientists are giving us the knowledge to achieve prevention, develop new treatments and a cure.

A R EAS O F FO C US

IN 2016, BCRF IS INVESTING $10 MILLION IN TUMOR BIOLOGY

FUNDING 44 PROJECTS


UNDERSTANDING RISK FACTORS: GENETICS, HEREDITY & ETHNICITY

A R E AS O F FO C US

A person’s family history, gender, age, race and ethnicity are all important risk factors for breast cancer. BCRF-funded research is improving our understanding of inherited gene mutations, developing low-cost genetic testing and developing targeted treatments for inherited cancers. Studies include prevention and early detection, the basic biology of BRCA-related breast and ovarian cancers, development and testing of novel therapies, identifying biomarkers of resistance to targeted therapies, racial disparities and clinical trials.

INHERITED RISKAbout 5 to 10 percent of breast cancers are thought to be caused by inherited genetic mutations.

BCRF-funded scientists Drs. Mary-Claire King at the University of Washington and Alan Ashworth at the University of California, San Francisco greatly advanced the field of hereditary breast cancer with their discoveries of the breast and ovarian cancer susceptibility genes, BRCA1 and

BRCA2. Other BCRF-funded scientists have discovered additional genetic links to aggressive breast cancers in Latin American and African American populations. Mutations in BRCA1 and BRCA2 have also been associated with a number of other cancers.

Research Highlights Dr. Mary-Claire King, Joan Marks and colleagues are leading the New York Breast Cancer Study to identify all genes, BRCA and others, responsible for inherited pre-disposition to breast cancer among women and men with Ashkenazi Jewish ancestry.

Drs. Fergus Couch, Katherine Nathanson and Kenneth Offit are studying the genome of over 21,000 patients with breast cancer and BRCA1 mutations, as well as over 4,000 with triple-negative breast cancer, to create a more personalized approach to risk assessment.

RACE AND ETHNICITYAlthough we know that mutations in certain genes increase a person’s chances of developing breast cancer, race and ethnicity are also important in understanding the development and aggressiveness of the disease.

Research Highlights BCRF grantee Dr. Christine Ambrosone is currently studying racial differences at the DNA level to increase our understanding of breast cancer biology, particularly for more aggressive triple negative breast cancers, which occur more frequently in African Americans compared to Caucasians.

INTERNATIONAL MEDICINEBCRF investigators are studying the disease internationally to improve breast cancer care in regions with limited access to healthcare.

Research Highlights Drs. Ephrat Levy-Lehad, Mary-Claire King and Moien Kanaan are studying the frequency of BRCA1 and BRCA2 mutations in Palestinian Arabs and non-Ashkenazi Jewish populations in Israel and the Middle East. Eleven new genetic mutations, in addition to BRCA1 and BRCA2 mutations, have been identified to date.

Identifying high-risk individuals is key to preventing breast cancer, and one way of doing so is to identify people with inherited mutations that increase their breast cancer risk. These risks may run in families, where frequent cancers occur, especially early in life, or across ethnicities, such as BRCA mutation in people of Ashkenazi Jewish ancestry.

Dr. Jeffrey Weitzel’s work in Latin America and Mexico is helping to create an infrastructure of genetic counselors and to develop low-cost genetic testing tools to apply in their home countries. Due to the lack of available genetic testing, we are only just beginning to learn about the level of inherited risk in Latin American populations.

Similarly, Dr. Funmi Olopade has made significant strides in Southwest Nigeria and Sub-Saharan countries. The project has identified major barriers to breast cancer care in Nigeria and is working on a variety of ways to address those barriers and improve access to care and train local clinicians.

IN 2016, BCRF IS INVESTING $5 MILLION IN HEREDITY & ETHNICITY RESEARCH

FUNDING 13 PROJECTS


LIFESTYLE INTERVENTIONSIt is never too late to make lifestyle changes. BCRF-funded research has shown that weight loss at any age significantly lowers breast cancer risk factors such as those controlling the blood vessels that support tumor growth.

Research HighlightsDr. Graham Colditz is studying how early life exposures affect normal adolescent growth and how these changes influence adult risk of breast cancer.

Drs. Walter Willet, Melinda Irwin and Ann McTiernan are examining how diet and exercise influence breast cancer risk and outcomes.

Drs. Andrew Dannenberg and Neil Iyengar are investigating the molecular changes induced by obesity to promote breast cancer development, progression and metastasis and develop new strategies to identify those at risk and effective interventions.

REDUCING THE RISK OF RECURRENCEThe five-year survival rate for early stage breast cancer (Stage

0-1) is nearly 100 percent. However, late recurrence—that is 10, 15 and even 20 years after initial diagnosis and treatment—remains a serious clinical concern. Understanding tumor biology is key to predicting those at high-risk of recurrence. For many high-risk women, chemoprevention with anti-estrogen therapies can dramatically reduce the risk of recurrence. Understanding which groups are at highest risk and ensuring access to screening and appropriate genetic counseling are key prevention strategies in this population.

Research HighlightsBCRF is supporting studies aimed at preventing recurrence by:• Testing novel approaches to improve risk stratification for

both women with and without breast cancer.• Developing promising interventions for breast cancer

prevention using biomarkers in blood or in normal breast tissue.

• Conducting clinical trials in chemoprevention in high-risk women.

• Understanding the frequency of BRCA 1/2 mutations in women of Ashkenazi Jewish descent without a family history of breast cancer.

REDUCING RISK: LIFESTYLE & PREVENTIONEach year 250,000 women and 2,000 men are diagnosed with breast cancer. Only about 10 percent of all breast cancer cases are caused by inherited genes (such as mutations in BRCA1, BRCA2 genes). So while the underlying causes of breast cancer are poorly understood, lifestyle and environment are key factors influencing cancer risk. Experts estimate that up to one half of cancer cases can be prevented through lifestyle choices and risk-reduction strategies. The same recommendations for prevention of heart disease, hypertension and diabetes (maintaining a healthy weight and regular exercise) may also reduce the risk of breast cancer.

A R EAS O F FO C US


OUTSMARTING CANCER: NEW TREATMENT APPROACHES


IN 2016, BCRF IS INVESTING $18 MILLION IN TREATMENT RESEARCH

FUNDING 68 PROJECTS

It is important to know that breast cancer is not just one disease. There are many different types of breast cancer that may present differently and have different treatments. The most common type of breast cancer is invasive ductal carcinoma. Invasive ductal carcinoma can be further classified in to several subcategories, including: • “Hormone sensitive,” or cancers fueled by the hormones

estrogen and progesterone (ER/PR positive). • “HER2+ positive,” or cancers driven by the HER2 gene. • ”Triple negative,” or cancers with none of the three

markers (do not express ER, PR or HER2).

Targeted therapies are available for breast cancers that are driven by hormone receptors or HER2, but for many breast cancers, including triple negative breast cancer, targeted therapies have not yet been approved in the U.S. Other types of breast cancer include invasive lobular carcinoma, inflammatory breast cancer, Paget disease of the nipple, and Phyllodes tumors which are less common and less studied types of breast cancer.

While significant progress has been made in developing new treatments for breast cancer over the last 25 years, much work remains. There is an urgent need for new treatments for people diagnosed with metastatic breast cancer (MBC), triple negative breast cancer, or breast cancers that are or have become resistant to available drugs.

Research HighlightsImmunotherapy is a promising new area of research but thorough study of the immune system and immune modulating drugs is needed. BCRF is investing $6.5 million this year into immune studies in breast cancer and immunotherapies.• Cancer vaccines are designed to stimulate the immune

system to fight cancer and provide “immune memory” to fight future cancer cells. Drs. Leisha Emens and Elizabeth Jaffee are testing a novel vaccine for breast cancer using intratumoral injection of an immune stimulant as a personalized vaccine.

• Immune Checkpoint Therapy: Immune checkpoint inhibitors (PD-L1/PD1 pathway) have shown great promise in cancer therapy. Drs. Lajos Pusztai and David Rimm have designed and lead the first clinical trials that test these agents in early stage triple negative breast cancer. They are also developing tests that will predict a cancer’s response to immune therapy drugs.

• Adoptive T-Cell Therapy: Anti-tumor immunity can by enhanced by a method called adoptive T-cell therapy, in which T-cells are obtained from patient blood, grown outside the body, tested to make sure that they recognize the patient’s cancer, and then infused back into the patient. Dr. Mary (Nora) Disis has developed a method to “supercharge” these T-cells against the cancer by making them secrete many different immune system molecules that help kill cancer, making them “polyfunctional.”

A class of drugs called CDK4/6 inhibitors, examples include palbociclib, abemaciclib and ribociclib, are generating much excitement as new therapeutic approaches in advanced ER/PR-positive breast cancers. As part of the Drug Research Collaborative, palbociclib was made available to BCRF investigators and is being studied in three of the six laboratory studies.

DRUG RESEARCH COLLABORATIVEIn 2016, BCRF launched the Drug Research Collaborative, an unprecedented new funding model aimed at bridging the gap between academic investigators and new drugs in development. BCRF has announced nine new projects that are part of this ground-breaking collaboration between BCRF, Pfizer and the Translational Breast Cancer Research Consortium (TBCRC). This program will be funded with an initial $15 million commitment from Pfizer along with newly available access to Pfizer’s broad portfolio of approved products and its pipeline of 16 oncology drugs still under development. The collaborative will support clinical trials that will be conducted and managed by the TBCRC. The three trials selected will test drugs under development for immunotherapy, cell cycle inhibition and kinase inhibition. Nearly 400 patients will be involved. Laboratory studies will advance our understanding of mechanisms of action of drugs, drug combinations and how to overcome resistance to current therapies.


Metastatic breast cancer occurs when breast cancer cells spread to other parts of the body, for instance the lungs, liver, brain or bones and form new tumors there. Metastatic breast cancer (MBC), sometimes referred to as stage IV or advanced breast cancer, is responsible for virtually all breast cancer-related deaths.

To metastasize, cancer cells have to leave the breast and get into the circulation, usually in the blood stream or lymphatic system. Next, cancer cells must find their way to another organ, enter the new organ, survive in that new environment and learn how to grow and divide uncontrollably in their new setting.

Research HighlightsDeveloping better treatments requires an understanding of all the processes of metastasis. In 2016, BCRF committed nearly 30 percent of its $57 million grant-making program to metastasis research. Projects span the spectrum of the cancer process to identify both early and late events that lead a cancer cell to become metastatic. BCRF investigators are using this information to devise ways to prevent metastasis from occurring and developing better treatments for late stage disease. They are developing model systems to accurately mimic the disease, studying tumor biopsies for the

identification of biomarkers that can predict drug response or resistance, and conducting well-designed clinical trials.

Dr. Sofia Merajver, BCRF investigator since 2004, is testing simple synthetic devices that mimic human organs. By placing live cancer cells from breast cancer patients inside the devices, Dr. Merajver’s team can study which cells are able to spread to distant sites, even before a tumor would be clinically detectable. These small inexpensive devices could dramatically improve breast cancer surveillance in remote areas and low resources settings.

Groundbreaking work by Dr. Kornelia Polyak, BCRF investigator since 2008, demonstrated the diversity of cells within a tumor and led the way for the study of tumor heterogeneity and advanced our understanding of the unique biology of cancer cells that spread from the breast compared to those that don’t.

Dr. Fabrice André, BCRF investigator since 2011 and his international colleagues are exploring this landscape to identify mutations in metastatic disease that could help explain drug resistance and lead to better treatments.

Evelyn H. Lauder Founder’s FundIn 2013, BCRF established the Evelyn H. Lauder Founder’s Fund, a multi-year international program dedicated to metastasis. Since then, BCRF has steadily developed the first large-scale global effort to unravel the biology of metastatic disease. With $30 million earmarked to date, BCRF’s Founder’s Fund is the largest privately funded project exclusively focused on metastasis in the world. This major initiative, called AURORA, is already under way, with teams in both Europe and the U.S. that

have undertaken research to shed light on why some breast cancers spread while others do not.

Metastatic Breast Cancer AllianceCritical data on metastatic breast cancer are missing: it is unknown how many people are living with metastatic disease today, how many early stage patients experience a recurrence, or how long women and men live after receiving a diagnosis of MBC. The Metastatic Breast Cancer Alliance (the Alliance) was formed in 2013 to address these and other urgent questions about MBC. Since 2015, BCRF has served as the administrative home of the Alliance and provides staff to serve the Alliance’s mission and to advance Alliance projects. BCRF staff are actively involved in solving unanswered questions in “MBC epidemiology” as well as exploring how to accelerate MBC research cooperatively with other Alliance members.

HOW CANCER SPREADS: METASTATIC BREAST CANCER

IN 2016, BCRF IS INVESTING $16 MILLION IN METASTATIC BREAST CANCER RESEARCH

FUNDING 20 PROJECTS

A R EAS O F FO C US

Nearly 100% of breast cancer deaths are due to metastatic breast cancer.

More than 400,000 American women and men die from breast cancer each year.

Up to 30% of early stage patients experience a recurrence and develop metastasis.


Advances in early detection and treatment have largely contributed to a decline in deaths due to breast cancer over the past two decades. With more than 3.5 million breast cancer survivors in the U.S., the largest cancer survivorship group in the country, addressing the physical, mental and emotional challenges faced by patients has become all the more important.

Just as breast cancer is a very heterogeneous disease, those diagnosed with breast cancer are a diverse group of people. Life after breast cancer is a unique experience for each woman or man and is influenced by many factors.

The goal of breast cancer treatment is to extend the lives of patients, but those life-saving treatments can have prolonged physical and emotional effects. Treatment-induced symptoms such as peripheral neuropathy (pain or numbness in the fingers or feet), lymphedema (build-up of lymph fluid under the skin causing uncomfortable swelling in the arms and hands), sexual dysfunction (such as vaginal dryness and loss of libido) and cognitive impairment (sometimes called chemo brain) can persist long after the treatment has ended. Because those affected by breast cancer are living longer, managing the long-term side effects of treatment is important to the quality of life during those extended years.

Research HighlightsWith BCRF support, researchers are working to personalize care and better predict and manage side effects, to not only increase lifespan with more effective therapies, but improve the quality of life for patients during and after treatment.

Drs. Debra Barton, Charles Loprinzi and Carol Fabian are investigating sexual health after breast cancer, including understanding how vaginal symptoms, fatigue, body image, and partner issues predict overall sexual health. They are also studying interventions for body image issues and testing non-estrogenic agents for the management of hot flashes.

BCRF Scientific Advisory Board Member and grantee Dr. Patricia Ganz seeks to understand how certain breast cancer treatments may accelerate the development of age-related cognitive decline.

Drs. Melinda Irwin and Elektra Paskett are investigating the role of diet, exercise, medication adherence and body weight on breast cancer and survivorship issues in women at high risk for breast cancer. They will also develop and test innovative biomedical and behavioral interventions for preventing breast cancer recurrence.

IMPROVING QUALITY OF LIFE: SURVIVORSHIP

One of the most important aspects of oncology is ensuring patients have the best quality of life possible.

-Dr. Patricia Ganz, BCRF Scientific Advisory Board Member



S U P P O RT F RO M COAS T TO COAS T

Boston, MADelta Breast Cancer One Flight: NYC to LA

Women’s Cancer Research Fund: Los Angeles, CA

The Pink Agenda: New York, NY

Palm Beach, FL

Long Island, NY

Play for P.I.N.K.: Boyton Beach, FL

Hamptons, NY

Independent Fundraiser: West Dover, VT Boston, MA


BCRF is honored to have such committed supporters around the world. Whether they contribute by attending a BCRF signature event, participating in an independent fundraiser or simply sharing our mission on social media, our community drives our ability to successfully fund research.

BCRF events raised over $16.6 million last year—funding 67 research grants. With the help of our dedicated supporters. BCRF’s footprint has indelibly marked the country from coast to coast with signature and regional events spreading across Boston, Hamptons, Westchester, Long Island and New York City, to Palm Beach, FL and Los Angeles, CA.

In 2016, the Women’s Cancer Research Fund (WCRF) joined forces with BCRF to go even further in its ability to fast-track more effective approaches to the study and early diagnosis of women’s cancers, with initial grants supporting funding in three areas of research: tumor biology and pathology, treatment for triple negative breast cancer, and developing model systems to better understand cancer behavior and metastasis.

Longtime partner Play for P.I.N.K. (PFP), a volunteer-driven organization that donates 100% of its proceeds to BCRF, once again successfully harnessed the power of volunteers across the country. In 2016, over 30,000 participants nationwide supported PFP through various sporting and lifestyle events raising $4.8 million for research.

The Pink Agenda (TPA) is an organization comprised of young professionals dedicated to funding breast cancer research in partnership with BCRF. In 2016, TPA’s millennial donor base raised nearly $650,000 via campaigns and events in New York, Atlanta, Boston and D.C. In collaboration with Giuliana Rancic’s FAB-U-WISH, TPA also grants wishes for young women currently undergoing treatment for breast cancer.

Volunteers and donors are working tirelessly to fund more research each and every day in a variety of ways. Independent fundraisers—both large and small—have contributed more than $4.4 million this year alone towards our shared vision of a world free of breast cancer.

EVENTS & COMMUNITY


Play for P.I.N.K.: Rancho Santa Fe, CAWomen’s Cancer Research Fund:Los Angeles, CA Independent Fundraiser: Boston, MA

The Pink Agenda: New York, NY

Ulta Beauty: Bolingbrook, IL

New York, NY

Boston, MA


BCRF’s focus on research was really compelling for us. We like being able to show our community the measurable impact of their donations in the spirit of transparency.

— Steven Izen, Founder and CEO, Lokai

Engaging with the private sector has been a core tenet of BCRF since it was founded by Evelyn Lauder alongside The Estée Lauder Companies’ Breast Cancer Awareness Campaign. Since 1993, partners have funded $297.5 million in research. Considered the gold standard in cause marketing by the New York State Attorney General’s Office, BCRF’s partnerships are authentically making an impact by harnessing the power of consumers, companies and the communities they reach.

$28.3 MILLIONTotal funds raised

by partners this year:

140

Number of total BCRF partners:

43%

Percentage of total BCRF revenue derived

from partner donations:

566,000Number of research

hours funded:

20 STATES 7 COUNTRIES

BCRF partners support 90 research grants in:

CORPORATE PARTNERSHIPS



Donors of $3,000,000 or moreANN INC., a division of ascena retail group inc.The Estée Lauder Companies Inc.Pfizer Inc.Play For P.I.N.K.Ulta Beauty

Donors of $1,000,000– $2,999,999AutoNation, Inc.Bloomberg PhilanthropiesBloomingdale’s, Inc.CareOne Charitable Fund/ Gwendolyn and Joseph StrausDelta Air LinesEstée Lauder Housewares Charity FoundationJ.C. Penney Corporation, Inc.The Lauder Foundation– Leonard & Judy Lauder FundMacy’s, Inc.Smart Circle/RGS Labs International, Inc.Women’s Cancer Research FundThe Wright Foundation Inc. Donors of $500,000– $999,999Cindy and Rob CitroneCliniqueEstée Lauder Field Force North AmericaEstée Lauder New York Area EmployeesKaren and Rob HaleKinga LampertMedical Research Charities/ Neighbor to NationTanger Factory OutletsJoseph and Arlene Taub Foundation Wilson Sporting Goods Co.

Donors of $250,000 - $499,999A Cure in Our LifetimeAlex and AniAscend HospiceAvedaAvon FoundationTory Burch

Estée Lauder Companies Canadian Operations FacilityThe Fashion Footwear Charitable Foundation/QVC Presents “FFANY Shoes on Sale”Genentech, Inc.Roslyn and Leslie GoldsteinHard Rock InternationalSusan and Roger HertogHudson’s Bay CompanyEvelyn H. Lauder CLATLokaiThe von Mandl Family FoundationEstate of Russell H. NorbergThe Pink Agenda®

The Garrett B. Smith Foundation– S. Arthur and Dorothy Neufeld FoundationThe Westchester Women

Donors of $100,000– $249,999Susan and Richard AndersonApollo Tools, Ltd.Armaly® BrandsJody and John ArnholdBirchBoxBobbi BrownBunco for Breast CancerCatherines, a division of ascena retail group inc.Celebrity CruisesLisa Pevaroff-Cohn and Gary CohnConair CorporationCondé NastD’Arrigo Bros. Co. of CaliforniaDavid YurmanDillard’s Inc.Eli Lilly and CompanyEstée Lauder Field - East CoastEstée Lauder London AffiliateEverlast Worldwide, Inc.FirmenichEstate of Deborah A. Cain FletcherAmy Goldman FowlerGoldman Sachs GivesThe Horace W. Goldsmith FoundationNeil and Jane Golub Family FoundationHearst CorporationHoliday HouseJo-Ann Fabric and Craft Stores

Jo MaloneWilliam P. LauderSamuel I. Newhouse Foundation Inc.Novartis OncologyOrlando Sports Foundation UCF EDRalph LaurenLily SafraThe Salon People/AvedaJeanne and Herbert SiegelSpring Meadow Nursery, Inc./Proven Winners® ColorChoice® ShrubsStage StoresSuffolk Construction CompanySuperior Plus Energy Services/ Griffith EnergyThe Tijuana Flats Just in Queso FoundationTommy Cares and PVH Foundation Donors of $50,000– $99,999Aramis & Designer FragrancesAstraZenecaAnne H. BassBee Sweet CitrusBNY MellonBrooks BrothersBumble and bumble.C.O. Bigelow Apothecaries/ Stephanie and Ian GinsbergDebra and Kenneth CaplanKate Capshaw and Steven Spielberg CAROLEECelgene CorporationChristopher & Banks CorporationClinique Field CanadaConquer Cancer Foundation of the American Society of Clinical OncologyCredit SuisseEisai OncologyEstée Lauder BCA Stronger TogetherEstée Lauder Field - CentralEstée Lauder Field - WestFairholme FoundationFirst Company Pink/Donna CioffiMindy and Jon GrayRachelle and Meyer Grodetsky

Hamptons Invitational Charity Pro-Am/ Dennis SuskindHanesBrands Inc.Healthy OnesIBM CorporationITU AbsorbTech, Inc.Kalope G. JamessonElton John Charitable FundCathy JollyJ.P. MorganLisa and David Klein/LEVIEVThe Kors Le Pere FoundationHeraeus KulzerLa MerLands’ End, Inc.LF StoresDan LufkinMr. and Mrs. Lawrence Mandel/ Key Food Stores Co-op Inc.Movado GroupNeiman Marcus GroupThe New York Community Trust – The Sharp Fund PLDMary M. O’HernParagon CorporatePerfumaniaLisa and Richard PerryPershing LLCPink Boat RegattaPittsburgh Penguins FoundationRadar Tires (Omni United)Abbe Raven and Martin TackelLois Robbins and Andrew ZaroRolling for PinkMara and Ricky SandlerMartin ShortJim and Marilyn SimonsThe Fred B. Snite FoundationDonna and James StearnsStrategic Distribution, L.P.Streamlight, Inc.SWK 1974 TrustTarget Corporation/Sonia KashukTime Inc.Tom Ford BeautyTory Burch, LLCTough Enough to Wear PinkToys “R” Us, Inc.Traders4ACauseTupperware Nordic A/STYR Sport, Inc.Candace King WeirWest Coast Novelty Corporation

We are grateful to the following donors for their generous support during the year ended June 30, 2016:


THE POWER OF PHILANTHROPY


Nina and Gary WexlerWorld Class Salons Donors of $25,000– $49,999ACCO Brands USA, LLCAlaska Run for WomenAlmira Family FoundationRoberta M. Amonascena retail group inc.Maria and Larry BaumJoan and Robert BlackmanBland Farms LLC.Stuart BoeskyThe Bon-Ton Stores, Inc.Benjamin BramIrma BramanLouise and David Braver Philanthropic FundAndrea and Erik BrooksShelly and Larry BrownBunco for Breast Cancer, Westmont, ILSusan and Alan Bushell/ Tour De BondvilleCabeauCafePress.comCalifornia CostumesEleanor S. Campbell-SwankCar Donation FoundationShelley and Michael CarrChiesa Shahinian & Giantomasi PCClear Vision OpticalClinique Field North AmericaCole Schotz P.C.Comfort RevolutionThe Company StoreSusan Crown and William KunklerCrystal & CompanyCuisinartLynn Dale and Frank Wisneski

The Ellen DeGeneres ShowDelta Sonic Car Wash Systems, Inc.Michele Docharty and Eric LinderDouglas Elliman/Dottie Herman and Howard Lorberdressbarn, a division of ascena retail group inc.Elburn Bunco for Breast Cancer (BFBC)Elite Business ProductionsJanice ElligEmpire Blue Cross Blue ShieldErnst & Young LLPESCADA US Estée Lauder - Belgium AffiliateEstée Lauder - Kabushiki KaishaAndrew L. FarkasFashion GroupFind a Cure RX CardFirst Republic BankFor Eyes OpticalLisa and Tomas FriedlanderAnne Marie GariadorGenomic HealthGivaudanMarjorie and Josh HarrisTommy and Dee HilfigerTodd Hitt and Michelle DolanskyThe Hunt Family Charitable FundInternational Flavors & Fragrances, Inc.Ivory Ella LLCJD Beauty GroupJoerns HealthcareWayne and Shelly JonesK & L Gates LLPK-2 SportsSinesia and Bill KarolNancy and Rick KelleherThe Kelly Cares FoundationKodiak Computer Services

Koi Design LLC.Sandra G. KrakoffLa Tortilla FactoryLab SeriesElyse LacherLaura and Steve LangJo Carole and Ronald S. LauderLaura and Gary LauderPetra and Stephen LevinLinda and Steven LevyLowenstein Sandler LLPThe Lynch FoundationJohn and Linda MacDonald FoundationMacroGenics, Inc.James R. MalekMANAManic Panic® NYCManion Gaynor & Manning LLPThe McCance Foundation TrustKristen and Patrick McMahonMemorial Sloan Kettering Cancer CenterHarold Michaels, Esq.MobilexModell’s Sporting GoodsThe Ambrose Monell FoundationMonello Landscape LLCMorgan StanleyNEST FragrancesNew York - Presbyterian HospitalThe New York TimesOgletree, Deakins, Nash, Smoak & Stewart, P.C.OriginsLiliane and the late Norman PeckPepsiCo FoodserviceKitty and Tim PinchPolo Ralph Lauren Foundation Pink Pony FundPopular

The Presto FoundationProfessional Bull Riders, LLCPatricia QuickTheodore A. Rapp FoundationAndrea Redmond and William FergusonLynda and Stewart ResnickWendi Rose/Marshall Rose Family FoundationPat and John RosenwaldRue La LaPheodora and Myung ShinEdna ShostakJackie and Bippy SiegalSmith Family FoundationSpectrum Brands, Inc.Stampin’ Up! Inc.Christina and Hal SteinbrennerCarl StieweDaniel and Brett SundheimSusanne’s Friends/Susanne FischerTeleflora LLCTFT Wheeling/Chantelle KernLizzie and Jonathan TischUS FoodsW.B. MasonThe Wasily Family FoundationWishes by Wyndham FoundationYourCause LLC Donors of $15,000– $24,999Catherine Adams/Teddy Bears to the RescueADF FieldAdvanta Medicaid LLCAmerican ExpressTracy AndersonApple and Eve, LLCArkay PackagingBeaucoup Swoozies LLCLloyd and Laura BlankfeinEmily and Leonard BlavatnikBlue Oak Charitable FundBlue Ridge OrthodonticsBosley MedicalClarissa and Edgar Bronfman, Jr.Rita and Charles BronfmanBuchanan Ingersoll & Rooney PCMrs. John J. ByrneCarpet One Floor & HomeLois Chiles and Richard GilderChino Basque ClubChopin Imports Ltd.Clovernook Country Club Women’s Golf Leagues/Connie U. WilliamsCoach WatchesCocktails for the CureThe Corner StopCrawl For Cancer Inc.Dana-Farber Cancer InstituteEllen and Gary Davis Foundation

Judy and Leonard A. Lauder


Delta Clipped Wings, Inc.Timothy DentDickinson + AssociatesEstate of Carol M. DietrichEdmonds Contracting, Inc.Katherine Farley and Jerry I. SpeyerSheri and Marc FeigenFor the Girls, Inc. Bill Ford and Marigay McKeeFoxRock PropertiesSamuel J. and Connie M. Frankino FoundationPaul Fribourg/Continental Grain CompanyGive With Liberty Employee DonationsGold Canyon International, LLC.Valerie and Gregory GorderGrandeur Peak Global Advisors, LLCHackensack University Medical CenterAlexandra HerzanJelly Belly Candy CompanyKekst and CompanyTimothy C. Kerr Family FoundationStacie and Stephan KiratsousSheila LambertThe Eleanor F. Langan Foundation of 1997Estate of Claire T. LecasLevittown Soccer Club/Pelini FundThe Lucille Roberts National Foundation for Women, Inc.Nancy and Howard MarksMassachusetts General Hospital Cancer CenterBlythe Masters and Gareth EvansMary Bryant McCourtMcDermott Will & EmeryMcKesson Medical-Surgical, Inc.Meadows FarmsMegabus North East LLCMercer (US) Inc.New York Football Giants Foundation, Inc.The New York Racing Association, Inc.NordstromJane and Daniel OchOfficemate International CorporationChristiane OlsenOuidad, Inc.Paint the Porch Pink

Cynthia Polsky/Lita Annenberg Hazen FoundationJohn RallisThe Bruce Robert Reid Family FoundationThe Rim Golf ClubRolex Watch USAR-Pharm US LLCJudith P. and S. Lawrence SchlagerSeminole Casino Coconut CreekCarl & Ruth Shapiro Family FoundationThe Muriel F. Siebert Foundation, Inc.David E. and Jacqueline S. Simon Charitable FoundationLaura and Harry SlatkinSmartLinx Solutions LLCSmashbox Beauty CosmeticsBarry S. Sternlicht/Starwood Capital GroupSunstar Americas, IncHenry and Marilyn Taub FoundationTCL North AmericaTeespring Inc.David ThiemeJamie Alexander TischTrudeau CorporationTrue Religion Brand JeansMaria Hummer-Tuttle and Robert TuttleThe United States Playing Card CompanyViolet Flower ShopVolkowitsch Golf OutingW.R. Berkley CorporationThe Walrath Family FoundationVera WangHollie WatmanWeil, Gotshal & MangesJ. Weinstein Foundation Inc.Westreich Finaly Foundation, Inc.Rita Wilson and Tom Hanks

Amy WinebrightWinston Flowers - Charity In BloomCarol YermalLee R. Zeidman Donors of $10,000–$14,99921st Century FoxBill AckmanDrs. Hugh Allen and Julie GralowStephanie Andrews and Marc WhiteAramis FieldArcher & GreinerAttic Needlework & CollectiblesDebbie and Glenn AugustBarneys New YorkBill Belichick and Linda HollidayStuart and Susan Bell Family FoundationBenefit Management Solutions Inc.Juliet and Joshua BerkowitzMichael and Marcela BerlandBerne ApparelBeth Israel Deaconess Medical CenterMyra and Charles BiblowitJane Sudler BlackPamela BlalockMarilyn D. BlantonMagda and Edward Bleier/ Dana FoundationLeslie Bluhm and David HelfandBernice BolligBoston Children’s HospitalThe Boston Pops and Keith LockhartThia Breen and Laurie DowleyBrigham and Women’s HospitalBarbara and Christopher BrodyArlene BuechertThe Buller Family Foundation/ Marjam Supply CompanyMr. and Mrs. Coleman P. Burke

The Dolores & Donald Burnett FoundationCalifornia Pear Advisory BoardCristina CarlinoLinda and Arthur CarterTip and Nino CatalanoCenturion Enterprises, LLCCF Global Trading, LLCClean Facilities Group, Inc.Richard & Martha ConwayCool Gear InternationalCore Staffing Services Inc.Jonathan Coslet and Jeanne RosnerCustom ShootoutHenri DaussiAna Demel and Gary SteinJohn D. DemseyDesigned for Health Care, LtdCharles and Valerie DikerKelly and Scott Donop/The Gold Coast Physical Therapy Golf OutingDooney & Bourke, Inc.Robert DowDyno LLCEagle CreekCarol Ann EmquiesEnglewood Hospital and Medical CenterStephanie ErcegovicEstée Lauder DubaiQuinn and Bryan EzralowRaysa FanjulJoseph FeshbachCathy Franklin and Jeffrey BakerMary-Ann and Fabrizio FredaFun Raisers Foundation, Inc.G & C Auto Body, Inc. CorporateGaiam Americas, Inc.The Gap, Inc.Johanna and Leslie GarfieldGCDC Marketing, IncThe David Geffen Foundation


Patrick Callahan, William Ferguson, Andrea Redmond, Mary Erdoes, Pat Rosenwald, John Rosenwald

Donors of $15,000–$24,999 (continued)


Mr. and Mrs. Philip H. Geier, Jr.Gold Medal InternationalJoseph and Dorothy Goldberg Charitable TrustJosh GoldstineMarjorie and Ellery GordonGROHEAudrey and Martin GrussThe Marc Haas Foundation/ Sydney and Stanley S. ShumanHardee Family FoundationHealthier ChoiceHeinz Family FoundationRonnie F. HeymanHoly Name Medical CenterLinda and Jay HooleyStephen P. HolmesPamela Stafford Huffman and Kurt HuffmanInLine Mechanical/Kevin HeckSteven IzenJacmel, Inc.Ellen and David JannettiJewish Federation of South Palm Beach CountyJohnson Family of RestaurantsKay and Robert JohnstoneJostens, Inc.Kansas Gymnastics and Dance CenterBarbara and Leo KarasMichele and Howard KesslerShelly and Howard KivellMyra J. KoltonStacey and Kevin KotlerDonald Kreiss Golf OutingKusmi TeaMaralyn and Kenneth LakinJane LauderMatthew T. LauerLemongrass SalonLifetime®

Jennifer and Marc LipschultzA Alberto LugoAlbert W. LutzMac’s Convenience Stores, LLCMadison Square Garden, L.P. Marycatherine & James Mamary/ Royal Health GroupMarimekko North America Retail LLCMaytronics US, Inc.Chris MeadRonay and Richard MenschelMicroflex CorporationLeeAnn L. MillerSydell L. MillerMMM Holdings, Inc.Moelis & Co.

The John A. Moran Charitable TrustRenee NadelSteven NapolitanoMichael NelsonJennifer and Josh NerenAndrea and Barry NewburgerNewmark Grubb Knight FrankStifel NicolausO2 CoolRita M. O’Hara Living TrustOptum360Paint the Parkway PinkMary Alice PappasPapyrus-Recycled Greetings, Inc.Paris Presents IncorporatedPauline K. MorganPentel of AmericaPetrlik Family FoundationCarole and Thom PhiebigPinnacle Quality InsightNancy and Fred PosesNili PoynterPrize Candle, LLCThomas C. QuickQuilts & Treasures, Inc.Rabbit AirKatharine J. RaynerRichards Homewares, Inc.Donna RichardsonMichele RiggiBarbara RobertsMark RobertsRolls-Royce Motor Cars NA, LLCThe May and Samuel Rudin Family Foundation, Inc.Paul RussoJoan SafirDennis SanchezSheryl and Barry K. SchwartzSentient Jet, LLCShaklee CorporationHeather and John ShemiltSilver Forest of VermontBarbara and Randall SmithJames Stanton and Kelli ShaughnessyStarpower Talent CompetitionSteve StronginS’wellSyde Hurdus Charitable FoundationSteven B. TangerTARA PearlsKaren and Marc TaubSusan O. TaylorTeach A Man To Fish FoundationTeaumen & Grace Fruite FoundationTechnical Gas Products

The TJX Companies, Inc.Michelle and Scott TesserUBSUnited Way of King CountyVan Cleef & ArpelsWachtell, Lipton, Rosen & KatzWedgewood Wedding & Banquet CenterCarol and Michael WeismanKimbra L. WilsonWith You LocketsJill and Paul YablonYMCA of Greater HoustonAerin Lauder ZinterhoferJodi and Adam Zotkow In-Kind Gifts Valued at $2,500 or MoreAda and Daniel de Maurier - de Lange InternationalAlex and AniAndy Boy/D’Arrigo Brothers Company of CaliforniaAnnabelle New YorkBagel BuoyBali Intimate ApparelBFFL Co.Boston Common MagazineBoston Harbor HotelBottega VenetaBrendan FallisBrooks BrothersButterfly BakeshopByron New York - Lake Road Consulting Corp.Cabeau, Inc.CAROLEECatherine T. KerriganCole HaanConair Corporation/Ron DiamondCool Gear InternationalDavid YurmanDee OcleppoDelta Air LinesDonna and James StearnsElyse LacherThe Estée Lauder Companies Inc.Ethan K.Fiji WaterFIKAFlywheel SportsGreg CalejoHampton Coffee CompanyHFZ Capital GroupHollie WatmanHoneydrop BeveragesJ. Walter ThompsonJelly Belly Candy CompanyKara Ross

Kravet Inc.Kusmi TeaLa MerLands’ End, Inc.Levon Graphics CorporationLoews HotelsMaralyn LakinMargot McKinney JewelleryMarian PaquetteMario Avila DesignMark Stephen Production LLCMcDermott Will & Emery, LLPMcKay WilliamsonMichael AramMichael KorsMoët Hennessy USANEST FragrancesNew York Health and Racquet ClubO.H.M. JewelryOuidad, Inc.Pentel of America, Inc.PMK FloralRafanelli EventsRamsey GemsRichard and Linda WillettRobert Epstein - Horizon Beverage CompanyRSVP Palm BeachRXR RealtySag Harbor Baking Co.Salon Mario RussoSandy AlexanderSPLASH MixersSurfari Crossroads GalleryTable 26 Palm BeachTaylor Creative Inc.Teleflora LLCThe Handbag RaincoatThe Juicy NaamThe New York TimesThe Wine Sisterhood in support of Tough Enough to Wear PinkTiffany & Co.Tory Burch, LLCTracy Anderson MethodTutto il GiornoUnity Electric Co., Inc.ValentinoVirginia Cocktail PeanutsThe von Mandl Family FoundationWeil, Gotshal & Manges LLPWest Coast NoveltyWill Stonebrink and Imtech GraphicsWinston Flowers

The Breast Cancer Research Foundation’s 2016 Major Donor List includes gifts received by the Foundation betweenJuly 1, 2015 through June 30, 2016. Every effort has been made to guarantee the accuracy of this list. Please contact us at 646-497-2612 or [email protected] if we have omitted your name or you wish to be listed differently in the future. Thank you for your support.


ARIZONAArizona State University

Karen Anderson, MD, PhDJoshua LaBaer, BS, PhD, MDThe Play for P.I.N.K. Award

University of ArizonaJorge Gomez, MD, MS, PhD

University of Arizona College of NursingUsha Menon, PhD, RN, FAAN

CALIFORNIACity of Hope

Arti Hurria, MDThe Delta Air Lines AwardPeter Lee, MDon behalf of Stand Up to Cancer (SU2C)Jeffrey N. Weitzel, MD

Cedars-Sinai Medical CenterHeather McArthur, MD, MPH The Lokai Award, The Cynthia Lufkin Award

Lawrence Berkeley National LaboratoryMina J. Bissell, PhD The Housewares Charity Foundation Award in Honorof Judy Colitz

Salk Institute for Biological StudiesGeoffrey M. Wahl, PhD The Play for P.I.N.K. Award in Honor of Stacy Small and in Memory of Sheila Kassa Small

Stanford UniversityMichael F. Clarke, MD The Hamptons Paddle & Party for Pink AwardChristina Curtis, PhD, MScThe ULTA Beauty AwardJames M. Ford, MDThe J.C. Penney AwardMark Pegram, MDGeorge Sledge, MD

University of California, IrvineEva Y.-H. P. Lee, PhD The ULTA Beauty AwardWenqi Wang, PhD American Association for Cancer ResearchClare Yu, PhDon behalf of Stand Up To Cancer

University of California, Los AngelesJulienne E. Bower, PhDThe Clinique AwardTom Chou, PhD Jayne Koskinas Ted Giovanis Foundation for Health and Policy PartnershipSteven W. Cole, PhD The Clinique AwardPatricia A. Ganz, MD The Estée Lauder AwardAnnette L. Stanton, PhD The ANN INC. Award, ANN INC. is a division of ascena retail group inc.

University of California, San DiegoAlan Ashworth, PhD, FRSThomas J. Kipps, MD, PhD The Macy’s AwardsBarbara A. Parker, MD The Macy’s Awards

University of California, San FranciscoAlan Ashworth, PhD, FRS

Laura Esserman, MD, MBA The ANN INC. Award, ANN INC. is a division of ascena retail group inc.Deanna Kroetz, PhD Hope S. Rugo, MD Laura van ‘t Veer, PhD

University of Southern California, Dornsife College of Letters, Arts and Science

James Hicks, PhD The AutoNation Cure Bowl AwardPeter Kuhn, PhD The AutoNation Cure Bowl Award

University of Southern California, Keck School of Medicine

David Agus, MD The Women’s Cancer Research Fund AwardPaul Macklin, PhD, PhD The Women’s Cancer Research Fund AwardMichael Press, MD, PhD The Bloomingdale’s Award

COLORADOUniversity of Colorado Denver

Kathryn B. Horwitz, PhD The Play for P.I.N.K. Award

CONNECTICUTYale School of Public Health

Melinda Irwin, PhD, MPH The ANN INC. Award, ANN INC. is a division of ascena retail group inc.

Yale University School of Medicine Christos Hatzis, PhD The Play for P.I.N.K. AwardLajos Pusztai, MD, DPhil David Rimm, MD, PhD The Estée Lauder Companies Brands Award in Memory of Evelyn H. Lauder

DCInstitute of Medicine/ National Academy of Sciences

Sharyl Nass, PhD The Play for P.I.N.K. Award

Georgetown University Medical CenterSandra Swain, MD The ANN INC. Award, ANN INC. is a division of ascena retail group inc.

FLORIDAMayo Clinic Cancer Center (Jacksonville, FL)

E. Aubrey Thompson, PhD The Play For P.I.N.K. Award

Moffitt Cancer CenterHeiko Enderling, PhD Jayne Koskinas Ted Giovanis Foundation for Health and Policy Partnership

University of Central Florida Annette R. Khaled, PhD The AutoNation Cure Bowl Award

University of Miami Tan A. Ince, MD, PhD The Play for P.I.N.K. Award in honor of Laura Lassman and in memory of Nicholas Lassman Marc E. Lippman, MD The Bloomingdale’s Award

Joyce M. Slingerland, MD, PhD The AutoNation Cure Bowl Award

GEORGIAGeorgia Institute of Technology

Stanislav Emelianov, PhDThe Amy Robach Award

ILLINOISLoyola University Chicago

Kathy S. Albain, MD The Housewares Charity Foundation Award Clodia Osipo, PhD The Housewares Charity Foundation Award

Northwestern University William J. Gradishar, MD The Housewares Charity Foundation AwardSeema A. Khan, MD The ANN INC. Award, ANN INC. is a division of ascena retail group inc.

University of Chicago Yoo-Jeong Han, PhD The ULTA Beauty Award Olufunmilayo I. Olopade, MB, BS, FACP The Estée Lauder Companies Brands Award in Memory of Evelyn H. Lauder, The ULTA Beauty Award

University of Illinois, Urbana-ChampaignJohn Katzenellenbogen, PhD The ULTA Beauty Award Benita S. Katzenellenbogen, PhD The Play for P.I.N.K. Award

INDIANAIndiana University School of Medicine

Kathy D. Miller, MD The ANN INC. Award, ANN INC. is a division of ascena retail group inc. Anna Maria Storniolo, MD The ULTA Beauty Award Richard Zellars, MDThe Delta Air Lines Award

KANSASUniversity of Kansas Medical Center

Carol J. Fabian, MD The ANN INC. Award, ANN INC. is a division of ascena retail group inc.Priyanka Sharma, MD Conquer Cancer Foundation of ASCO

MARYLANDJohns Hopkins University Bloomberg School of Public Health

Kala Visvanathan, MBBS, FRACP, MHS The ANN INC. Award, ANN INC. is a division of ascena retail group inc.

Johns Hopkins University School of Medicine

Leisha Emens, MD, PhD Andrew Ewald, PhD The Pink Agenda Award, Jayne Koskinas Ted Giovanis Foundation for Health and Policy PartnershipDaniele Gilkes, PhD Jayne Koskinas Ted Giovanis Foundation for Health and Policy Partnership

Elizabeth Jaffee, MDBen Park, MD, PhD The ULTA Beauty AwardAndrea Richardson, MD, PhD The J.C. Penney AwardDipali Sharma, PhD Vered Stearns, MD The Estée Lauder AwardAntonio Wolff, MD on behalf of EORTC/TBCRC/BIG/NABCG

National Institutes of HealthPeter Greenwald, MD, DrPH

University of Maryland Fengtian Xue, PhD American Association for Cancer Research

Walter Reed National Military Medical Center, John P. Murtha Cancer Center

Col. Craig Shriver, MD, FACS

MASSACHUSETTSBeth Israel Deaconess Medical Center

Xiuning Le, MD, PhD The Hirschhorn Award in Honor of Susan B. Hirschhorn and in Memory of Her Mother, Ellen S. Hirschhorn, Conquer Cancer Foundation of ASCOPier Paolo Pandolfi, MD, PhD Stuart Schnitt, MD The Housewares Charity Foundation AwardNadine Tung, MD The Housewares Charity Foundation AwardGerburg Wulf, MD, PhD

Boston Children’s Hospital Marsha Moses, PhD The Clinique AwardZoltan Szallasi, MD

Brigham and Women’s Hospital Mehra Golshan, MDThe Hale Family Award

Brigham and Women’s Hospital/Harvard Medical School

Ross Berkowitz, MD The Play for P.I.N.K. Award

Dana-Farber Cancer InstituteMyles Brown, MD The Pink Promises Award in Memory of Patricia L. HansenNancy Lin, MD The ANN INC. Award, ANN INC. is a division of ascena retail group inc.

Dana-Farber Cancer Insititute/Harvard Medical School

Alan D’Andrea, MD Ian Krop, MD, PhD David Livingston, MD Ursula Matulonis, MD The Play for P.I.N.K. AwardKornelia Polyak, MD, PhD The ULTA Beauty AwardEric Winer, MD The ANN INC. Award, ANN INC. is a division of ascena retail group incJean Zhao, PhDThe Hale Family Award

2 0 1 6 –2 0 1 7 G RA N T E E S


Dana-Farber Cancer Institute/Harvard Medical School/Brigham And Women’s Hospital

Monica Bertagnolli, MD The ANN INC. Award ANN INC. is a division of ascena retail group inc.Judy Garber, MD, MPH The Gwendolyn and Joseph Straus - CareOne Charitable Fund AwardWilliam Kaelin, MD Ann Partridge, MD, MPH The Pink Agenda AwardZhigang Wang, MD, PhD The Play for P.I.N.K. Award, The Hale Family Award

Harvard Medical School Joan Brugge, PhD The Bloomingdale’s Award

Harvard School of Public Health Walter Willett, MD, DrPH The Wilson Sporting Goods Award

Massachusetts General Hospital Daniel Haber, MD, PhD Dennis Sgroi, MD Boston Hot Pink Luncheon Award in Honor of Nancy and Rick Kelleher

Massachusetts Institute of Technology

Darrell Irvine, PhDon behalf of Stand Up To Cancer

The Broad InstituteNikhil Wagle, MD

Tufts University School of MedicineCharlotte Kuperwasser, PhD Alex and Ani Award

Whitehead Institute for Biomedical Research

Robert Weinberg, PhD The Lampert Foundation Award

MICHIGANMichigan State University

Karen Liby, PhDUniversity of Michigan

Daniel Hayes, MD The Genentech Award, The Macy’s AwardSofia Merajver, MD, PhD The Delta Air Lines AwardAki Morikawa, MD, PhD Conquer Cancer Foundation of ASCOLori Pierce, MD, FASTRO The ULTA Beauty AwardJames Rae, PhD The Macy’s AwardShaomeng Wang, PhD The J.C. Penney AwardStephen Weiss, MD Max Wicha, MD

University of Michigan School of Nursing

Debra L. Barton, RN, PhDVan Andel Research Institute

Carrie Graveel, PhD George Vande Woude, PhD

MINNESOTAMayo Clinic Cancer Center (Rochester, MN)

Fergus J. Couch, PhD The ULTA Beauty AwardJames N. Ingle, MD The Smart Circle/The RGS Labs International AwardCharles L. Loprinzi, MD Liewei Wang, MD, PhD The Smart Circle/RGS Labs International Award

MISSOURIWashington University in St. Louis

Graham A. Colditz, DrPH, MD, MPH The ANN INC. Award, ANN INC. is a division of ascena retail group inc.Cynthia X. Ma, MD, PhD on behalf of the Alliance for Clinical Trials in Oncology

NEW HAMPSHIREDartmouth College

Michael Sporn, MD

NEW JERSEYPrinceton University

Yibin Kang, PhD The Macy’s Award

Rutgers Cancer Institute of New Jersey

Joseph Bertino, MD The Play for P.I.N.K. AwardDarren Carpizo, MD, PhD The Gwendolyn and Joseph Straus - CareOne Charitable Fund AwardShridar Ganesan, MD, PhD The Gwendolyn and Joseph Straus - CareOne Charitable Fund AwardBruce Haffty, MD The Gwendolyn and Joseph Straus - CareOne Charitable Fund Award

NEW YORKAlbert Einstein College of Medicine

Rachel Hazan, PhD The First Step Award Through QVC and FashionFootwear Charitable Foundation Susan Horwitz, PhD The Housewares Charity Foundation Award in Honor of Terry LundgrenHayley McDaid, PhD The Housewares Charity Foundation Award in Honor of Terry LundgrenThomas Rohan, MD, PhD The Estée Lauder Companies Brands Award in Memory of Evelyn H. Lauder

Cold Spring Harbor Laboratory Gurinder Singh (Mickey) Atwal, PhDon behalf of Stand Up To CancerMichael Wigler, PhD The Play for P.I.N.K. Award

Columbia UniversityDawn Hershman, MD, MS The ANN INC. Award, ANN INC. is a division of ascena retail group inc., Conquer Cancer Foundation of ASCO

Columbia University Mailman School of Public Health

Lauren C. Houghton, PhDRegina Santella, PhD The Aveda AwardMary Beth Terry, PhD The Aveda Award

Hunter College, City University of New YorkJill Bargonetti, PhD The Estée Lauder Companies Brands Award in memory of Evelyn H. Lauder

Icahn School of Medicine at Mount Sinai

Stuart Aaronson, MD The Westchester Women’s AwardHanna Irie, MD, PhD The Women’s Cancer Research Fund AwardElisa Port, MD, FACS The Women’s Cancer Research Fund Award

Memorial Sloan Kettering Cancer CenterJose Baselga, MD, PhD Tory Burch Award, The Cure in Our Lifetime AwardRobert Benezra, PhD The Play for P.I.N.K. AwardSarat Chandarlapaty, MD, PhD Tory Burch AwardElizabeth Comen, MD The Lampert Foundation AwardMonica Fornier, MD The Estée Lauder Companies North America Supply Chain & Operating Facilities AwardHedvig Hricak, MD, PhD The Delta Air Lines AwardNeil Iyengar, MD Conquer Cancer Foundation of ASCO, The Deborah Krulewitch AwardTaha Merghoub, PhD The Play for P.I.N.K. AwardLarry Norton, MD The Tory Burch Award, The First Step Award through QVC and Fashion Footwear Charitable FoundationKenneth Offit, MD, MPH The Sandra Taub Memorial AwardSimon Powell, MD, PhD Jorge Reis-Filho, MD, PhD The Estée Lauder Companies North America Supply Chain & Operating Facilities AwardMark Robson, MD The Sandra Taub Memorial AwardNeal Rosen, MD, PhD The Joseph and Arlene Taub Foundation AwardMaurizio Scaltriti, PhD Tory Burch AwardStephen Solomon, MDThe Cynthia Lufkin AwardJedd Wolchok, MD, PhD The Play for P.I.N.K. Award

Montefiore Medical Center/Albert Einstein College of Medicine

Joseph A. Sparano, MD on behalf of Coalition of Cancer Cooperative Groups

NYU School of Medicine Francisco Esteva, MD, PhD The Smart Circle/The RGS Labs International Award Robert Schneider, PhD The Hamptons Paddle & Party for Pink Award

Roswell Park Cancer Institute Christine Ambrosone, PhD The ULTA Beauty Award Chi-Chen Hong, PhD The ULTA Beauty Award

Sarah Lawrence College Joan Marks, MS

The Rockefeller UniversityTitia de Lange, PhD The Bloomingdale’s AwardMichael O’Donnell, PhD Sohail Tavazoie, MD, PhD The Lampert Foundation Award

Weill Cornell Medical CollegeLewis Cantley, PhD The Estée Lauder Companies Brands Award in memory of Evelyn H. Lauder

Andrew Dannenberg, MD The Bloomingdale’s AwardSandra Demaria, MDThe ULTA Beauty Award

Silvia Formenti, MD The ULTA Beauty AwardWilliam Holloman, PhD

NORTH CAROLINADuke University

Shelley Hwang, MD, MPH The Tanger Outlets AwardTerry Hyslop, PhDon behalf of Alliance for Clinical Trials in Oncology

University of North Carolina, Chapel Hill

Carey Anders, MD Conquer Cancer Foundation of ASCOLisa Carey, MD The Pink Promises AwardH. Shelton Earp, MD The Estée Lauder AwardStephen Hursting, PhD, MPH The ANN INC. Award, ANN INC. is a division of ascena retail group inc.Hyman Muss, MD The Play for P.I.N.K. AwardCharles Perou, PhD The Susan Hertog AwardKatherine Reeder-Hayes, MD, MBA The ANN INC. Award, ANN INC. is a division of ascena retail group inc. Conquer Cancer Foundation of ASCO

OHIOCleveland Clinic

Charis Eng, MD, PhD, FACP The von Mandl Family Award

Ohio State University Electra D. Paskett, PhD, MSPH The Play for P.I.N.K. Award

OREGONOregon Health and Science University

Laura Heiser, PhD Jayne Koskinas Ted Giovanis Foundation for Health and Policy Partnership

PENNSYLVANIABaruch S. Blumberg Institute

Richard Pestell, MB, BS, PhD, MD, FACP The ULTA Beauty Award

Coalition of Cancer Cooperative Groups and Eastern Cooperative Oncology Group

Robert L. Comis, MD The Lewis P. Janowsky Memorial Award

National Surgical Adjucant Breast and Bowel Project (NSABP)

Norman Wolmark, MDUniversity of Pennsylvania, Abramson Cancer Center

Lawrence Shulman, MD University of Pennsylvania, Perelman School of MedicineIra Bleiweiss, MD The Women’s Cancer Research Fund AwardLewis Chodosh, MD, PhD The Hamptons Paddle & Party for Pink AwardAngela DeMichele, MD, MSCE Susan Domchek, MD The Hamptons Paddle & Party for Pink AwardMark Greene, MD, PhD, FRCP The Play for P.I.N.K. AwardKatherine Nathanson, MD The Tanger Outlets AwardSandra Ryeom, PhD The Garrett B. Smith Foundation/S. Arthur


*As of January 2017

and Dorothy Neufeld Foundation AwardRobert Vonderheide, MD, DPhil The Hamptons Paddle & Party for Pink Award

University of Pittsburgh Cancer Institute

Wendie Berg, PhD, FACR Thirty Three Foundation AwardThomas Kensler, PhD The Maria Angelica Calandriello AwardAdrian Lee, PhD The Meredith Israel Thomas AwardSteffi Oesterreich, PhD The Pittsburgh Penguin Foundation Award

TENNESSEEVanderbilt University

Carlos L. Arteaga, MD The Play for P.I.N.K. AwardDavid Cortez, PhD The Smart Circle/The RGS Labs International AwardAnna Vilgelm, PhD

TEXASBaylor College of Medicine

Matthew Ellis, MB, BChir, PhD The Joan Lunden AwardSuzanne Fuqua, PhD The Play for P.I.N.K. AwardC. Kent Osborne, MD The Macy’s AwardRachel Schiff, PhD The Macy’s AwardXiang Zhang, PhD

Houston Methodist Research Institute

Jenny C. Chang, MD The Estée Lauder Award

Rice UniversityHerbert Levine, PhDon behalf of Stand Up To Cancer

University of Texas MD Anderson Cancer Center

Michael Andreeff, MD, PhDThe AutoNation Cure Bowl AwardPowel Brown, MD, PhD The J.C. Penney AwardZhen Fan, MD The Story Half Told - Pfizer Oncology MBC Research AwardSharon Giordano, MD, MPH The Play for P.I.N.K. AwardGabriel Hortobagyi, MD, FACP, FASCO Mien-Chie Hung, PhD Gordon Mills, MD, PhD Sangeetha Reddy, MD, MSc Conquer Cancer Foundation of ASCOW. Fraser Symmans, MD The ULTA Beauty Award

WASHINGTONFred Hutchinson Cancer Research Center

Nancy Davidson, MD The ANN INC. Award, ANN INC. is a division of ascena retail group inc.Cyrus Ghajar, PhD Anne McTiernan, MD, PhD The Delta Air Lines AwardPeggy Porter, MD The Play for P.I.N.K. Awardon behalf of EORTC/TBCRC/BIG/NABCG

University of WashingtonMary Disis, MD The ULTA Beauty AwardJulie Gralow, MD The Play for P.I.N.K. Awardon behalf of SWOGMary-Claire King, PhD The Roz and Les Goldstein AwardSasha Stanton, MD, PhD American Association for Cancer Research

WISCONSINUniversity of Wisconsin

Vincent L. Cryns, MD The Housewares Charity Foundation Award

INTERNATIONAL

ARGENTINALatin American and Carribean Society of Medical Oncology (SLACOM)

Eduardo Cazap, MD, PhD, FASCO

AUSTRALIAUniversity of Melbourne, Peter Maccallum Cancer Centre

Sherene Loi, MD, PhD University of Newcastle

John F Forbes, MB BS, FRACS, AM The Delta Air Lines Award on behalf of Australia and New Zealand Breast Cancer Trials Group (ANZBCTG)

BELGIUMInstitut Jules Bordet

Martine J. Piccart-Gebhart, MD, PhD The Hamptons Paddle & Party for Pink Award, on behalf of Breast International Group (BIG)Christos Sotiriou, MD, PhD

CANADAMount Sinai Hospital/University of Toronto

Pamela J. Goodwin, MD, MSc, FRCPC The Hudson’s Bay Company Award

Ontario Institute for Cancer ResearchJohn Bartlett, PhD The Play for P.I.N.K. Award

Queen’s University Lois E. Shepherd, MDCM, FRCPC The ANN INC. Award, ANN INC. is a division of ascena retail group inc.

FRANCEInstitut Curie/Hospital Rene Huguenin

Rosette Lidereau, PhD The Delta Air Lines Award

Institut Gustave Roussy Fabrice André, MD, PhD The Estée Lauder Companies Brands Award in memory of Evelyn H. Lauder

ISRAELClalit National Israeli Cancer Control Center (NICCC)

Gad Rennert, MD, PhDShaare Zedek Medical Center

Ephrat Levy-Lahad, MD The Roz and Les Goldstein Award

Tel Aviv University Ilan Tsarfaty, PhD

ITALYHospital of Prato, Instituto Toscano Tumori

Laura Biganzoli, MD, PhD The Estée Lauder Companies North America Supply Chain & Operating Facilities Award Angelo Di Leo, MD, PhD

PALESTINIAN AUTHORITYBethlehem University

Moien Kanaan, PhD The Roz and Les Goldstein Award

PORTUGALChampalimaud Cancer Center

Fatima Cardoso, MD The Play for P.I.N.K. Award on behalf of EORTC/TBCRC/BIG/NABCG

RWANDAButaro Hospital

Tharcisse Mpunga, MD

SPAINVall D’hebron Institute of Oncology

Joaquín Arribas, PhD

SWITZERLANDInternational Breast Cancer Study Group

Meredith Regan, ScD The ANN INC. Award, ANN INC. is a division of ascena retail group inc.

University of LausanneJohanna Joyce, PhD The ANN INC. Award, ANN INC. is a division of ascena retail group inc.

UNITED KINGDOMBrighton and Sussex Medical School, Shore-C

Dame Lesley Fallowfield, DBE, BSc, DPhil, MedSci The Estée Lauder Companies Brands Award in Memory of Evelyn H. Lauder

Queen Mary, University of London Jack Cuzick, BSc, MSc, PhDThe Delta Air Lines Awardon behalf of Australia and New Zealand

Breast Cancer Trials Group (ANZBCTG)Royal Marsden Hospital

Mitch Dowsett, FMedSci, PhD The Estée Lauder Companies Brands Award in Honor of Elizabeth HurleyIan Smith, MD, FRCP, FRCPE The Estée Lauder Companies Brands Award in Honor of Elizabeth Hurley

The Francis Crick Institute/ The Rockefeller University

Sir Paul Nurse, PhD, FRS The Sir Elton John Award

University of CambridgeKerstin Meyer, BSc, PhD Sir Bruce Ponder, FRCP, FMedSci, FRS

University of OxfordAdrian Harris, MD, DPhil The Housewares Charity Foundation Award

University College of London Cancer Institute

Charles Swanton, MD, PhD The Hamptons Paddle & Party for Pink Award

2 0 1 6 –2 0 1 7 G RA N T E E S

BCRF researchers at the 2016 October Symposium & Awards Luncheon


In 2016-2017, BCRF is investing $57 million to support the work of more than 250 scientists at leading medical and academic institutions across 14 countries, making BCRF the largest private funder of breast cancer research worldwide. By committing 91 cents of every dollar directly to its mission, BCRF remains one of the nation’s most fiscally responsible nonprofits.

BCRF has been recognized as one of the most financially efficient nonprofits in the country.

BCRF has earned the highest rating of 4 stars from Charity Navigator for the 14th time since 2002.

CharityWatch has designated BCRF an “A+” charity, the highest possible rating. BCRF is currently the only breast cancer

organization in the U.S. to to hold this top ranking.

91%

STATEMENT OF ACTIVITIES FOR THE YEAR ENDED JUNE 30, 2016PUBLIC SUPPORT AND REVENUEPUBLIC SUPPORT:Contributions Special Events Less: Direct benefit to donor costs

Total public support

REVENUE:Grant refundsNet investment lossForeign currency lossTotal revenue

Total public support and revenue

EXPENSES:Program ServicesManagement and GeneralFundraising

Total expenses

Change in net assets

STATEMENT OF ACTIVITIES FOR THE YEAR ENDED JUNE 30, 2016ASSETS:CashPledges receivableInvestmentsPrepaid expenses and other receivablesProperty and equipment, netSecurity Deposit

Total assets

LIABILITIES AND NET ASSETS:Liabilities:Accounts payable and accrued expenses Grants Payable

Total liabilities

Net assets:UnrestrictedTemporarily RestrictedPermanently Restricted

Total net assets

Total liabilities and net assets

$ 53,497,03915,334,356

(2,494,743)

$ 66,336,652

$ 40,122,628

40,373,11810,556,902

712,415 110,350

40,061

$ 91,915,474

$ 320,16569,730,204

$ 70,050,369

$ 18,497,9611,817,1441,550,000

$ 21,865,105

$ 91,915,474

$ 232,080 (126,411)

(69,072)36,597

$ 66,373,249

$ 60,627,698 2,275,2655,458,170

$ 68,361,133

$ (1,987,884)

FPO

BEST IN CLASS

Goes to Breast Cancer Research & Awareness Programs

THE BREAST CANCER RESEARCH FOUNDATION60 East 56th Street, 8th floorNew York, NY 10022(646) 497-2600

www.bcrfcure.org

BCRFcure

facebook.com/TheBreastCancerResearchFoundation

twitter.com/bcrfcure

annual report 2016 · joanne smith donna m. stearns elizabeth straus arlene taub karen taub jamie...

Documents